I 116th CONGRESS 2d Session H. R. 8190 IN THE HOUSE OF REPRESENTATIVES September 8, 2020 Mr. Grothman introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes.